Gerber »

Monopar Therapeutics shares owned by Gerber

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Gerber from 13F filings

Historical chart of Gerber investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Gerber consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Gerber

Quarter filed Position value Share count Share price at filing
2025-09-30 $457k 5.6k 81.67
2025-06-30 $200k 5.6k 35.78
2025-03-31 $204k 5.6k 36.41

More positions owned by Gerber

Etf Ser Solutions Aptus Defined (DRSK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Covington Trust Enhanced Intl (FENI)
Ark Etf Tr Innovation Etf (ARKK)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Aon Shs Cl A (AON)
NVIDIA Corporation (NVDA)
Amplify Etf Tr Blockchain Ldr (BLOK)
Apple (AAPL)
Ark Etf Tr Fintech Innova (ARKF)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Microsoft Corporation (MSFT)
Coinbase Global Com Cl A (COIN)

View all positions for Gerber

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics